My Member
Message Center
trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
-
Inactivated vaccines can't end outbreak, but suitable to protect general public: experts
Experts explained although the approved inactivated vaccines cannot cure the infected, they are suitable for China to protect the general public.
2021-01-07 -
Biotech firm makes test kit for new virus variant
BGI Genomics, a Shenzhen-based biotech company, on Tuesday announced the successful development of a rapid detection kit for the new strain of the novel coronavirus, known as SARS-CoV-2 B.1.1.7, which was originally discovered in the UK.
2021-01-06 -
Sinopharm's vaccine shows protection rate of over 79%
Sinopharm's COVID-19 vaccine can induce neutralizing antibody in 99.52 percent of recipients, and has a 79.34 percent efficacy rate, according to midterm clinical results released on Wednesday.
2020-12-30 -
Drug offers new way to limit spread of HIV
The market launch of a drug that prevents HIV infection, the first of its kind in China, will contribute to the fight against the AIDS disease the virus can cause, leading medical experts said.
2020-12-28 -
China's self-developed lung cancer drug available nationwide
HANGZHOU - Ensartinib hydrochloride, a targeted drug for lung cancer developed by a Chinese firm, has been available in hospitals and pharmacies nationwide since Wednesday, according to its developer Beta Pharma.
2020-12-22 -
Official affirms safety of Chinese vaccines
Experimental COVID-19 vaccines developed by Chinese researchers are safe, and ongoing efforts to push for their market approval will strictly follow the rules of science, a health official said on Monday.
2020-12-22 -
Anti-depression drug fluvoxamine can prevent deterioration of mild COVID-19 infections
None of the 80 infected subjects who received fluvoxamine treatment for 15 days experienced deterioration in their health, while six persons in the placebo group all suffered deterioration, according to the research.
2020-12-16 -
China's centralized drug-procurement program provides cheaper medicines
Fifty-five types of medicine listed in China's third-round centralized drug-procurement program have become available in public hospitals across the country at much lower prices, the National Healthcare Security Administration said Thursday.
2020-12-04 -
Eye health education platform to focus on medics, public
An eye health medical personnel incubating institute worked with an online medical care resources platform to give momentum to China's eye health industry and raise it to an international level.
2020-12-03 -
Sinopharm submits market approval application for COVID vaccine
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to China's top market regulator, Xinhua News Agency quoted the company's deputy general manager Shi Shengyi as saying on Wednesday.
2020-12-01